CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

74 hedge funds and large institutions have $61.9M invested in CytomX Therapeutics in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 27 closing their positions.

Holders
74
Holders Change
-14
Holders Change %
-15.91%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
29
Reduced
24
Closed
27
Calls
$30K
Puts
$43K
Net Calls
-$13K
Net Calls Change
-$356K

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$7.72M
2
TCM
2
Tang Capital Management
California
$9.51M
3
RI
3
RTW Investments
New York
$1.46M
4
Millennium Management
4
Millennium Management
New York
$2.25M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$3.66M

Top Sellers

1
O
1
OrbiMed
New York
$0
2
SCM
2
Sio Capital Management
New York
$0
3
BCM
3
Bronte Capital Management
Australia
$0
4
BI
4
BVF Inc
California
$6.38M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$31.6K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
101
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$0 248 +248 New
1 2 3 4
5